Economic Value of Shingles Vaccination—March 2026

Economic Value of Shingles Vaccination—March 2026

Canadian Economic Analysis Health and Healthcare
3 min read

Author: Signal49 Research

$0.00

This web page introduces upcoming research from Signal49 on the value of adult vaccination for shingles and its benefits for healthy aging.

Want a discount? Become a member by purchasing a subscription! Learn More

Guarding Health, Driving Productivity: The Economic Value of Shingles Vaccination

Healthy aging helps older adults continue contributing to the economy through employment, caregiving, volunteering, and community engagement. Vaccinating against shingles—which affects one in three Canadian adults—can prevent infections and their negative outcomes.

What is the return on investment for vaccinating against shingles? What needs to change to realize better outcomes from shingles vaccinations? Where in society can value be added through an improved process for vaccination?

Read the online experience to find out more.

Questions?

Call 1-888-801-8818 or send us a message (Mon–Fri: 8 am to 5 pm).

This field is hidden when viewing the form
This field is hidden when viewing the form

Require an accessible version of this research?

Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.

Learn more about our accessibility policies.

Reviews

Be the first to review “Economic Value of Shingles Vaccination—March 2026”

There are no reviews yet.